Table 2.
Participant characteristics.
| Reference | Participant condition | Country | Females, n (%) | Age, mean (SD or range) |
| Gardner-Nix et al, 2008 [41] | Chronic pain | Canada | 162 (75.3) | 52 (32-79) |
| Davis and Zautra, 2013 [42] | Fibromyalgia | United States | 77 (98) | 46.14 (22-81) |
| Boettcher et al, 2014 [43] | Anxiety disorders | Sweden | 65 (71) | 38 (10.3) |
| Ly et al, 2014 [44] | Major depressive disorder | Sweden | 57 (70) | 36 (10.8) |
| Zernicke et al, 2014 [45] | Cancer recovery | Canada | 45 (73) | 57.6 (10.8) |
| Dimidjian et al, 2014 [46] | Residual depressive symptoms | United States | 146 (73.0) | 47.4 (11.43) |
| Younge et al, 2015 [36]; Gotink et al, 2017 [37] | Heart disease | The Netherlands | 150 (46.3) | 43.2 (27.5) |
| Dowd et al, 2015 [47] | Chronic pain | Ireland | 112 (90.3) | 44.5 (12.3) |
| Moritz et al, 2015 [48] | Psychosis | Germany | 52 (58) | 37.7 (9.7) |
| Henriksson et al, 2016 [49] | Chronic pain | Sweden | 100 (93.5) | 51 (9.3) |